TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23950601

Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 21078681

Group type: EXPERIMENTAL
Intervention: Rizatriptan 10-mg ODT
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study: 19647431

Group type: EXPERIMENTAL
Intervention: Single-masking
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Intra-observer reliability
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Multi-masking
Number of subjects: 4
Study: 18042619

Group type: EXPERIMENTAL
Intervention: Conventional pacing at 70 min(‐1)
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: Preventive pacing with four therapies
Number of subjects: 372

Group type: COMPARATOR
Intervention: Single rate pacing at 40 min(‐1)
Number of subjects: 372
Study: 15058255

Group type: EXPERIMENTAL
Intervention: Transmyocardial laser revascularization (TMLR) alone
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Combination of CABG and TMLR (CABG/TMLR group)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 62
Study: 10736287

Group type: EXPERIMENTAL
Intervention: Intravenous T(3) at 0.4 microg/kg
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Intravenous T(3) at 0.6 microg/kg
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Intravenous T(3) at 0.8 microg/kg
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 8725414

Group type: EXPERIMENTAL
Intervention: Hypothermic CPB (rectal temperature 27 to 28 degrees C)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Normothermic CPB (rectal temperature > 36 degrees C)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Hypothermic CPB
Number of subjects: 30

Group type: COMPARATOR
Intervention: Normothermic CPB
Number of subjects: 30
Study: 1446756

Group type: EXPERIMENTAL
Intervention: Topical timolol
Number of subjects: 59
Study: 3967835

Group type: EXPERIMENTAL
Intervention: Double blind placebo controlled food challenges
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 29524287

Group type: EXPERIMENTAL
Intervention: Aquatide™
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 0
Study: 28923492

Group type: EXPERIMENTAL
Intervention: ECA/Kardia intervention (smartphone-based Embodied Conversational Agent and Alive Cor Kardia Mobile heart rhythm monitor)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Standard of care (symptom and adherence journal)
Number of subjects: 180
Study: 25808572

Group type: EXPERIMENTAL
Intervention: Lornoxicam 8 mg
Number of subjects: 57

Group type: COMPARATOR
Intervention: Ibuprofen 400 mg
Number of subjects: 57
Study: 22407959

Group type: EXPERIMENTAL
Intervention: Third-person expressive writing
Number of subjects: 0

Group type: COMPARATOR
Intervention: First-person expressive writing
Number of subjects: 0
Study: 20711135

Group type: EXPERIMENTAL
Intervention: 600 mg/day of alpha lipoic acid for two months
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 300 mg/day of gabapentin for two months
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Combination of 600 mg/day of alpha lipoic acid and 300 mg/day of gabapentin for two months
Number of subjects: 120

Group type: COMPARATOR
Intervention: 100 mg/day of cellulose starch for two months
Number of subjects: 120
Study: 19907100

Group type: EXPERIMENTAL
Intervention: Pitavastatin 2 mg/day for 12 months
Number of subjects: 45
Study: 17115015

Group type: EXPERIMENTAL
Intervention: MCT/LCT emulsion (50:50)
Number of subjects: 24

Group type: COMPARATOR
Intervention: LCT emulsion (100%)
Number of subjects: 24
Study: 15531028

Group type: EXPERIMENTAL
Intervention: Priorix
Number of subjects: 620

Group type: COMPARATOR
Intervention: RORVax
Number of subjects: 620
Study: 11557159

Group type: EXPERIMENTAL
Intervention: Ketamine (0.1‐0.5 mg/kg)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Ketamine (0.3 mg/kg)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 35
Study: 9500318

Group type: EXPERIMENTAL
Intervention: sublingual/oral immunotherapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study: 8719303

Group type: EXPERIMENTAL
Intervention: GHRH (1 microgram/kg/bw iv bolus at 0 and 120 min)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: GHRH followed by hexarelin (1 microgram/kg/bw iv bolus at 0 and 120 min)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Hexarelin (1 microgram/kg/bw iv bolus at 0 and 120 min)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: GHRH (second bolus)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Hexarelin (after first GHRH bolus)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Repeated hexarelin administration
Number of subjects: 6
Study: 2703387

Group type: EXPERIMENTAL
Intervention: Misonidazole (MISO) 1 g/m2/d with brachytherapy for ENT tumors
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Misonidazole (MISO) 1 g/m2/d with hypofractionated external radiotherapy for breast cancer
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Misonidazole (MISO) 1 g/m2/d with hypofractionated external radiotherapy for large ENT tumors
Number of subjects: 46
Study: 329375

Group type: EXPERIMENTAL
Intervention: Secretolytic agents
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 31971034

Group type: EXPERIMENTAL
Intervention: Antipsoriatic drugs (10 drugs including 3 oral medications and 7 biologic agents)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PASI alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Duration of treatment alone
Number of subjects: 0
Study: 30484743

Group type: EXPERIMENTAL
Intervention: Parenting Wisely web-based modules coupled with text messaging
Number of subjects: 37

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 37
Study: 29137509

Group type: EXPERIMENTAL
Intervention: Research abstract from a high-income country
Number of subjects: 347

Group type: COMPARATOR
Intervention: Research abstract from a low-income country
Number of subjects: 347
Study: 25999201

Group type: EXPERIMENTAL
Intervention: Retention Intervention (RI)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Delayed Retention Intervention (DRI)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control (NFP as usual)
Number of subjects: 26
Study: 24263878

Group type: EXPERIMENTAL
Intervention: Hatha yoga exercises (6 individually-applied sessions with ongoing home practice)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 45
Study: 22070722

Group type: EXPERIMENTAL
Intervention: Differentiated muscle training exercises under physiotherapeutic instruction, followed by independent performance by patients.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Physiotherapy with respiratory therapy and 'hot roll' treatment on radiation treatment days.
Number of subjects: 60
Study: 19238697

Group type: EXPERIMENTAL
Intervention: Aban Aya prevention curriculum delivered by trained parent educators
Number of subjects: 0
Study: 16278069

Group type: EXPERIMENTAL
Intervention: Aceclofenac administered preoperatively (2 tablets of 100 mg taken orally 1h before surgery)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Aceclofenac administered postoperatively (2 tablets of 100 mg taken orally in the early postoperative period)
Number of subjects: 40
Study: 12499964

Group type: EXPERIMENTAL
Intervention: Triangular osteosynthesis
Number of subjects: 12

Group type: COMPARATOR
Intervention: Iliosacral screw fixation
Number of subjects: 12
Study: 10476974

Group type: EXPERIMENTAL
Intervention: Plyometric training (15 minutes of plyometrics supplemented to 1.25 hours of swimming, 3 times per week for 20 weeks)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (1.5 hours of swimming, 3 times per week for 20 weeks)
Number of subjects: 38
Study: 8961972

Group type: EXPERIMENTAL
Intervention: Tamoxifen therapy beyond 5 years
Number of subjects: 194

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Tamoxifen therapy for estrogen receptor-positive tumors
Number of subjects: 194
Study: 1842806

Group type: EXPERIMENTAL
Intervention: Low dose oral quinine (1050 mg in two divided doses daily for five days)
Number of subjects: 0
Study: 7129168

Group type: EXPERIMENTAL
Intervention: Didactic training (imagery techniques taught)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Problem-solving training (practical solutions for everyday difficulties)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait list (control group)
Number of subjects: 0
Study: 3907823

Group type: EXPERIMENTAL
Intervention: Bromocriptine, 18-150 mg/day (mean, 72.5)
Number of subjects: 15
Study: 30048858

Group type: EXPERIMENTAL
Intervention: SAA, NO, and CRP levels in septic shock (A) group
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: NO levels in septic shock (A) group
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: SAA, CRP, and NO levels in death (D) group
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: APACHE II score in death (D) group
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: SAA, NO, and CRP levels
Number of subjects: 100
Study: 27283947

Group type: EXPERIMENTAL
Intervention: Vinpocetine 30 mg intravenously once daily for 7 days
Number of subjects: 610

Group type: COMPARATOR
Intervention: Control group (cytidine disphosphate choline + aspirin/clopidogrel)
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: Vinpocetine
Number of subjects: 610
Study: 24876712

Group type: EXPERIMENTAL
Intervention: Full strength formocresol
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 1:5 diluted formocresol
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 1:25 diluted formocresol
Number of subjects: 90
Study: 22652556

Group type: EXPERIMENTAL
Intervention: Calcifediol (Hidroferol®, 1 ampoule: 266 μg) administered weekly after HD for 6 doses
Number of subjects: 59

Group type: COMPARATOR
Intervention: Untreated patients (controls)
Number of subjects: 59
Study: 20492442

Group type: EXPERIMENTAL
Intervention: Self-etch composite cement (Panavia Fluoro cement) applied by dental students
Number of subjects: 16

Group type: COMPARATOR
Intervention: Self-etch composite cement (Panavia Fluoro cement) applied by trained dentists
Number of subjects: 16
Study: 18818572

Group type: EXPERIMENTAL
Intervention: Aspirin + cilostazol
Number of subjects: 20

Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 20
Study: 15879923

Group type: EXPERIMENTAL
Intervention: 0.05 mg/day vaginal ring
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: 0.1 mg/day vaginal ring
Number of subjects: 174

Group type: COMPARATOR
Intervention: 0.0075 mg/day vaginal ring (active comparator)
Number of subjects: 174
Study: 12915827

Group type: EXPERIMENTAL
Intervention: Atorvastatin (10 to 20 mg)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 187
Study: 10690149

Group type: EXPERIMENTAL
Intervention: Self-prepared heparinized syringes
Number of subjects: 30

Group type: COMPARATOR
Intervention: Commercially manufactured dry balanced heparinized syringes
Number of subjects: 30
Study: 8759656

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg b.i.d.
Number of subjects: 19

Group type: COMPARATOR
Intervention: Omeprazole 40 mg qAM
Number of subjects: 19

Group type: COMPARATOR
Intervention: Omeprazole 40 mg qPM
Number of subjects: 19

Group type: COMPARATOR
Intervention: All regimens of omeprazole 40 mg
Number of subjects: 19
Study: 1681275

Group type: EXPERIMENTAL
Intervention: Personal letters to patients outlining their cancer consultation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no letters)
Number of subjects: 0
Study: 6759285

Group type: EXPERIMENTAL
Intervention: Verapamil 480 mg daily
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Nifedipine 60 mg daily
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 31285414

Group type: EXPERIMENTAL
Intervention: Intra-articular injection of Tranexamic Acid (TXA) 1.5 g in 50 ml normal saline
Number of subjects: 101

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 101
Study: 28665556

Group type: COMPARATOR
Intervention: T-PEP
Number of subjects: 120

Group type: COMPARATOR
Intervention: O-PEP
Number of subjects: 120
Study: 27362791

Group type: EXPERIMENTAL
Intervention: Yohimbine-augmented CBT
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo-augmented CBT
Number of subjects: 39
Study: 24131861

Group type: EXPERIMENTAL
Intervention: Focal psychodynamic therapy
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Enhanced cognitive behaviour therapy
Number of subjects: 242

Group type: COMPARATOR
Intervention: Optimised treatment as usual
Number of subjects: 242
Study: 20970283

Group type: EXPERIMENTAL
Intervention: GRACE score
Number of subjects: 2263

Group type: EXPERIMENTAL
Intervention: TIMI score
Number of subjects: 2263

Group type: EXPERIMENTAL
Intervention: Age alone
Number of subjects: 2263

Group type: COMPARATOR
Intervention: Major adverse events
Number of subjects: 2263
Study: 20555281

Group type: EXPERIMENTAL
Intervention: Warm-up and stretch (WS)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Stretching only (SO)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control condition (CON)
Number of subjects: 30
Study: 18635499

Group type: EXPERIMENTAL
Intervention: 1000 microg ultrapurified capsaicin (ALGRX 4975)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 16473229

Group type: EXPERIMENTAL
Intervention: Propofol/Fentanyl (P/F group)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Ketamine/Midazolam (K/M group)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study: 11994058

Group type: EXPERIMENTAL
Intervention: Chlorpheniramine alone (8 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Chlorpheniramine with quinidine (50 mg every 6 h for 2 days prior and during the study)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Chlorpheniramine alone
Number of subjects: 8
Study: 10654755

Group type: EXPERIMENTAL
Intervention: Aminophylline cream applied twice daily to one thigh/buttock (placebo on the other)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Endermologie treatment applied twice weekly to one thigh/buttock
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Endermologie treatment applied to both thighs/buttocks with the same cream regimen as group 1
Number of subjects: 52
Study: 9121998

Group type: EXPERIMENTAL
Intervention: Before treatment (I)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: On the 3rd treatment week (II)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: After achievement of euthyroid (III)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 14
Study: 1929772

Group type: EXPERIMENTAL
Intervention: Clomipramine hydrochloride (mean dose 120 +/- 48 mg/d)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Desipramine hydrochloride (mean dose 135 +/- 53 mg/d)
Number of subjects: 25
Study: 6617219

Group type: EXPERIMENTAL
Intervention: Radial catheter insertion
Number of subjects: 155

Group type: COMPARATOR
Intervention: Femoral catheter insertion
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Both femoral and radial catheters
Number of subjects: 155
Study: 29297147

Group type: EXPERIMENTAL
Intervention: Heart rate variability biofeedback (HRV-BF)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 210
Study: 27150263

Group type: EXPERIMENTAL
Intervention: 1 kHz Interferential Current (IFC)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 4 kHz Interferential Current (IFC)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Active groups (1 kHz and 4 kHz)
Number of subjects: 150
Study: 25283070

Group type: EXPERIMENTAL
Intervention: Augmented visual feedback training (VFT)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Conventional balance training (Control)
Number of subjects: 33
Study: 22676430

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) provided by MSWs in clients' homes
Number of subjects: 0
Study: 20374078

Group type: EXPERIMENTAL
Intervention: RimabotulinumtoxinB (BoNT‐B)
Number of subjects: 0
Study: 17586596

Group type: EXPERIMENTAL
Intervention: BNP testing
Number of subjects: 452

Group type: COMPARATOR
Intervention: Standard assessment (control)
Number of subjects: 452
Study: 16563240

Group type: EXPERIMENTAL
Intervention: EnSite-NavX system (group I, n = 40)
Number of subjects: 75

Group type: COMPARATOR
Intervention: CARTO system (group II, n = 35)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: EnSite-NavX system (group I)
Number of subjects: 75

Group type: COMPARATOR
Intervention: CARTO system (group II)
Number of subjects: 75
Study: 12149503

Group type: EXPERIMENTAL
Intervention: Cetirizine (0.25 mg/kg twice a day over 18 months)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 600
Study: 9495403

Group type: EXPERIMENTAL
Intervention: Feedback group
Number of subjects: 27
Study: 7650070

Group type: EXPERIMENTAL
Intervention: Single oral dose of 50 mg flurbiprofen
Number of subjects: 12

Group type: COMPARATOR
Intervention: Single topical application of a 40 mg flurbiprofen patch
Number of subjects: 12

Group type: COMPARATOR
Intervention: Repeated application of the topical patch (twice daily for 7 days)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Topical patch
Number of subjects: 12
Study: 2745390

Group type: EXPERIMENTAL
Intervention: Fenfluramine 1.5 mg/kg daily for 3 months
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Fenfluramine
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Initial HVA levels
Number of subjects: 13
Study: 1115706

Group type: EXPERIMENTAL
Intervention: Backscatter from intense pulse light (10 light pulses from a Grimes '360 strobe')
Number of subjects: 20

Group type: COMPARATOR
Intervention: No backscatter (no light pulses)
Number of subjects: 20
Study: 31047901

Group type: EXPERIMENTAL
Intervention: Data-driven cluster analysis for selecting glucose-lowering therapy
Number of subjects: 4351

Group type: COMPARATOR
Intervention: Simple clinical features (sex, BMI, age at diagnosis, baseline HbA1c)
Number of subjects: 4351

Group type: COMPARATOR
Intervention: Age at diagnosis for glycaemic progression
Number of subjects: 4351

Group type: COMPARATOR
Intervention: Estimated glomerular filtration rate at baseline
Number of subjects: 4351
Study: 27474192

Group type: EXPERIMENTAL
Intervention: Narrowband blue light (λmax 458‐480 nm, n = 23)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Narrowband green light (λmax 551‐555 nm, n = 25)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Darkness control (0 lux, n = 12)
Number of subjects: 60
Study: 24445278

Group type: EXPERIMENTAL
Intervention: Tadalafil 5 mg
Number of subjects: 1500
Study: 23768260

Group type: EXPERIMENTAL
Intervention: Panic-focused psychodynamic psychotherapy (PFPP)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Cognitive-behavioral therapy (CBT) plus exposure therapy
Number of subjects: 54
Study: 20202971

Group type: EXPERIMENTAL
Intervention: Bosentan
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Bosentan + Sildenafil
Number of subjects: 21
Study: 19157318

Group type: EXPERIMENTAL
Intervention: Methadone (20-60 mg daily, tapered over 2 weeks)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Methadone + TENS (10-30 mg daily, tapered over 2 weeks with TENS treatment)
Number of subjects: 45

Group type: COMPARATOR
Intervention: TENS (low frequency 2 Hz for two weeks)
Number of subjects: 45
Study: 16791665

Group type: COMPARATOR
Intervention: Saline 0.9%
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Colloids (gelatin 4%, hydroxyethyl starch 6%, albumin 5%)
Number of subjects: 67
Study: 12603405

Group type: EXPERIMENTAL
Intervention: Radical cystectomy with urostomy
Number of subjects: 306

Group type: COMPARATOR
Intervention: Control group (normal population)
Number of subjects: 306
Study: 10978264

Group type: EXPERIMENTAL
Intervention: Recombinant hirudin
Number of subjects: 67

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 67
Study: 8817264

Group type: EXPERIMENTAL
Intervention: Normal digital sensibility
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Local anesthesia of the index finger and thumb
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Forearm-support condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: No-support condition
Number of subjects: 0
Study: 7930339

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (10 mg intravenous dose)
Number of subjects: 12
Study: 3168338

Group type: EXPERIMENTAL
Intervention: Ionic amidotrizoate (370 mg/ml, osmolality 2.1 osmol/kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nonionic iopamidol (370 mg/ml, osmolality 0.8 osmol/kg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Both contrast media
Number of subjects: 10
Study: 31286672

Group type: EXPERIMENTAL
Intervention: Neutropenic diet
Number of subjects: 23
Study: 28655900

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 IU)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 27194309

Group type: EXPERIMENTAL
Intervention: Behavioral nutrition intervention
Number of subjects: 136
Study: 23407696

Group type: EXPERIMENTAL
Intervention: Normothermic (NMTH) group (n = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Hypothermic (HPTH) group (n = 20)
Number of subjects: 40
Study: 21188414

Group type: EXPERIMENTAL
Intervention: Clicking task with low mental load
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Clicking task with high mental load (mental arithmetic)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Rest condition
Number of subjects: 43
Study: 20002085

Group type: EXPERIMENTAL
Intervention: 400 mg voriconazole orally
Number of subjects: 20

Group type: COMPARATOR
Intervention: 400 mg voriconazole intravenously
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both routes of administration
Number of subjects: 20
Study: 16894074

Group type: EXPERIMENTAL
Intervention: HIV intervention
Number of subjects: 553

Group type: COMPARATOR
Intervention: Health‐promotion intervention
Number of subjects: 553
Study: 14750014

Group type: EXPERIMENTAL
Intervention: Sensorimotor training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Strength training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0